 | • レポートコード：MRC2Q12-19405 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、SB-525334のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 SB-525334のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 SB-525334の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 SB-525334のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのSB-525334の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のSB-525334の売上および2028年までの予測に焦点を当てています。 SB-525334のグローバル主要企業には、Accel Pharmtech、Ambeed、APExBIO Technology、Arctom Scientific、Biorbyt、Biosynth Carbosynth、Cayman Chemical、ChemScence、Creative Enzymes、Crysdot、Dalton Research Molecules、Glentham Life Sciences、Sigma-Aldrich(Merck KGaA)、Tocris Bioscience、Tokyo Chemical Industry(TCI)、Toronto Research Chemicals、ChemFacesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 SB-525334市場は、タイプとアプリケーションによって区分されます。世界のSB-525334市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.95、0.97、0.99 【アプリケーション別セグメント】 肺動脈性肺高血圧症、間葉系腫瘍 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - SB-525334製品概要 - タイプ別市場（0.95、0.97、0.99） - アプリケーション別市場（肺動脈性肺高血圧症、間葉系腫瘍） - 調査の目的 ・エグゼクティブサマリー - 世界のSB-525334販売量予測2017-2028 - 世界のSB-525334売上予測2017-2028 - SB-525334の地域別販売量 - SB-525334の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別SB-525334販売量 - 主要メーカー別SB-525334売上 - 主要メーカー別SB-525334価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.95、0.97、0.99） - SB-525334のタイプ別販売量 - SB-525334のタイプ別売上 - SB-525334のタイプ別価格 ・アプリケーション別市場規模（肺動脈性肺高血圧症、間葉系腫瘍） - SB-525334のアプリケーション別販売量 - SB-525334のアプリケーション別売上 - SB-525334のアプリケーション別価格 ・北米市場 - 北米のSB-525334市場規模（タイプ別、アプリケーション別） - 主要国別のSB-525334市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのSB-525334市場規模（タイプ別、アプリケーション別） - 主要国別のSB-525334市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のSB-525334市場規模（タイプ別、アプリケーション別） - 主要国別のSB-525334市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のSB-525334市場規模（タイプ別、アプリケーション別） - 主要国別のSB-525334市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのSB-525334市場規模（タイプ別、アプリケーション別） - 主要国別のSB-525334市場規模（トルコ、サウジアラビア） ・企業情報 Accel Pharmtech、Ambeed、APExBIO Technology、Arctom Scientific、Biorbyt、Biosynth Carbosynth、Cayman Chemical、ChemScence、Creative Enzymes、Crysdot、Dalton Research Molecules、Glentham Life Sciences、Sigma-Aldrich(Merck KGaA)、Tocris Bioscience、Tokyo Chemical Industry(TCI)、Toronto Research Chemicals、ChemFaces ・産業チェーン及び販売チャネル分析 - SB-525334の産業チェーン分析 - SB-525334の原材料 - SB-525334の生産プロセス - SB-525334の販売及びマーケティング - SB-525334の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - SB-525334の産業動向 - SB-525334のマーケットドライバー - SB-525334の課題 - SB-525334の阻害要因 ・主な調査結果 |
SB-525334 is a potent and selective inhibitor of the TGF-β1R and ALK5 (IC50: 14.3 nM).
Market Analysis and Insights: Global SB-525334 Market
Due to the COVID-19 pandemic, the global SB-525334 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.95 accounting for % of the SB-525334 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pulmonary Arterial Hypertension segment is altered to an % CAGR throughout this forecast period.
China SB-525334 market size is valued at US$ million in 2021, while the US and Europe SB-525334 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe SB-525334 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of SB-525334 include Accel Pharmtech, Ambeed, APExBIO Technology, Arctom Scientific, Biorbyt, Biosynth Carbosynth, Cayman Chemical, ChemScence and Creative Enzymes, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global SB-525334 Scope and Segment
SB-525334 market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global SB-525334 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
0.95
0.97
0.99
Segment by Application
Pulmonary Arterial Hypertension
Mesenchymal Tumors
By Company
Accel Pharmtech
Ambeed
APExBIO Technology
Arctom Scientific
Biorbyt
Biosynth Carbosynth
Cayman Chemical
ChemScence
Creative Enzymes
Crysdot
Dalton Research Molecules
Glentham Life Sciences
Sigma-Aldrich(Merck KGaA)
Tocris Bioscience
Tokyo Chemical Industry(TCI)
Toronto Research Chemicals
ChemFaces
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 SB-525334 Product Introduction
1.2 Market by Purity
1.2.1 Global SB-525334 Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 0.95
1.2.3 0.97
1.2.4 0.99
1.3 Market by Application
1.3.1 Global SB-525334 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pulmonary Arterial Hypertension
1.3.3 Mesenchymal Tumors
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global SB-525334 Sales Estimates and Forecasts 2017-2028
2.2 Global SB-525334 Revenue Estimates and Forecasts 2017-2028
2.3 Global SB-525334 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global SB-525334 Sales by Region
2.4.1 Global SB-525334 Sales by Region (2017-2022)
2.4.2 Global Sales SB-525334 by Region (2023-2028)
2.5 Global SB-525334 Revenue by Region
2.5.1 Global SB-525334 Revenue by Region (2017-2022)
2.5.2 Global SB-525334 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global SB-525334 Sales by Manufacturers
3.1.1 Global Top SB-525334 Manufacturers by Sales (2017-2022)
3.1.2 Global SB-525334 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SB-525334 in 2021
3.2 Global SB-525334 Revenue by Manufacturers
3.2.1 Global SB-525334 Revenue by Manufacturers (2017-2022)
3.2.2 Global SB-525334 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by SB-525334 Revenue in 2021
3.3 Global SB-525334 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global SB-525334 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global SB-525334 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
4.1 Global SB-525334 Sales by Purity
4.1.1 Global SB-525334 Historical Sales by Purity (2017-2022)
4.1.2 Global SB-525334 Forecasted Sales by Purity (2023-2028)
4.1.3 Global SB-525334 Sales Market Share by Purity (2017-2028)
4.2 Global SB-525334 Revenue by Purity
4.2.1 Global SB-525334 Historical Revenue by Purity (2017-2022)
4.2.2 Global SB-525334 Forecasted Revenue by Purity (2023-2028)
4.2.3 Global SB-525334 Revenue Market Share by Purity (2017-2028)
4.3 Global SB-525334 Price by Purity
4.3.1 Global SB-525334 Price by Purity (2017-2022)
4.3.2 Global SB-525334 Price Forecast by Purity (2023-2028)
5 Market Size by Application
5.1 Global SB-525334 Sales by Application
5.1.1 Global SB-525334 Historical Sales by Application (2017-2022)
5.1.2 Global SB-525334 Forecasted Sales by Application (2023-2028)
5.1.3 Global SB-525334 Sales Market Share by Application (2017-2028)
5.2 Global SB-525334 Revenue by Application
5.2.1 Global SB-525334 Historical Revenue by Application (2017-2022)
5.2.2 Global SB-525334 Forecasted Revenue by Application (2023-2028)
5.2.3 Global SB-525334 Revenue Market Share by Application (2017-2028)
5.3 Global SB-525334 Price by Application
5.3.1 Global SB-525334 Price by Application (2017-2022)
5.3.2 Global SB-525334 Price Forecast by Application (2023-2028)
6 North America
6.1 North America SB-525334 Market Size by Purity
6.1.1 North America SB-525334 Sales by Purity (2017-2028)
6.1.2 North America SB-525334 Revenue by Purity (2017-2028)
6.2 North America SB-525334 Market Size by Application
6.2.1 North America SB-525334 Sales by Application (2017-2028)
6.2.2 North America SB-525334 Revenue by Application (2017-2028)
6.3 North America SB-525334 Market Size by Country
6.3.1 North America SB-525334 Sales by Country (2017-2028)
6.3.2 North America SB-525334 Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe SB-525334 Market Size by Purity
7.1.1 Europe SB-525334 Sales by Purity (2017-2028)
7.1.2 Europe SB-525334 Revenue by Purity (2017-2028)
7.2 Europe SB-525334 Market Size by Application
7.2.1 Europe SB-525334 Sales by Application (2017-2028)
7.2.2 Europe SB-525334 Revenue by Application (2017-2028)
7.3 Europe SB-525334 Market Size by Country
7.3.1 Europe SB-525334 Sales by Country (2017-2028)
7.3.2 Europe SB-525334 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific SB-525334 Market Size by Purity
8.1.1 Asia Pacific SB-525334 Sales by Purity (2017-2028)
8.1.2 Asia Pacific SB-525334 Revenue by Purity (2017-2028)
8.2 Asia Pacific SB-525334 Market Size by Application
8.2.1 Asia Pacific SB-525334 Sales by Application (2017-2028)
8.2.2 Asia Pacific SB-525334 Revenue by Application (2017-2028)
8.3 Asia Pacific SB-525334 Market Size by Region
8.3.1 Asia Pacific SB-525334 Sales by Region (2017-2028)
8.3.2 Asia Pacific SB-525334 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America SB-525334 Market Size by Purity
9.1.1 Latin America SB-525334 Sales by Purity (2017-2028)
9.1.2 Latin America SB-525334 Revenue by Purity (2017-2028)
9.2 Latin America SB-525334 Market Size by Application
9.2.1 Latin America SB-525334 Sales by Application (2017-2028)
9.2.2 Latin America SB-525334 Revenue by Application (2017-2028)
9.3 Latin America SB-525334 Market Size by Country
9.3.1 Latin America SB-525334 Sales by Country (2017-2028)
9.3.2 Latin America SB-525334 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa SB-525334 Market Size by Purity
10.1.1 Middle East and Africa SB-525334 Sales by Purity (2017-2028)
10.1.2 Middle East and Africa SB-525334 Revenue by Purity (2017-2028)
10.2 Middle East and Africa SB-525334 Market Size by Application
10.2.1 Middle East and Africa SB-525334 Sales by Application (2017-2028)
10.2.2 Middle East and Africa SB-525334 Revenue by Application (2017-2028)
10.3 Middle East and Africa SB-525334 Market Size by Country
10.3.1 Middle East and Africa SB-525334 Sales by Country (2017-2028)
10.3.2 Middle East and Africa SB-525334 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Accel Pharmtech
11.1.1 Accel Pharmtech Corporation Information
11.1.2 Accel Pharmtech Overview
11.1.3 Accel Pharmtech SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Accel Pharmtech SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Accel Pharmtech Recent Developments
11.2 Ambeed
11.2.1 Ambeed Corporation Information
11.2.2 Ambeed Overview
11.2.3 Ambeed SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ambeed SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ambeed Recent Developments
11.3 APExBIO Technology
11.3.1 APExBIO Technology Corporation Information
11.3.2 APExBIO Technology Overview
11.3.3 APExBIO Technology SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 APExBIO Technology SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 APExBIO Technology Recent Developments
11.4 Arctom Scientific
11.4.1 Arctom Scientific Corporation Information
11.4.2 Arctom Scientific Overview
11.4.3 Arctom Scientific SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Arctom Scientific SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arctom Scientific Recent Developments
11.5 Biorbyt
11.5.1 Biorbyt Corporation Information
11.5.2 Biorbyt Overview
11.5.3 Biorbyt SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biorbyt SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biorbyt Recent Developments
11.6 Biosynth Carbosynth
11.6.1 Biosynth Carbosynth Corporation Information
11.6.2 Biosynth Carbosynth Overview
11.6.3 Biosynth Carbosynth SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biosynth Carbosynth SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosynth Carbosynth Recent Developments
11.7 Cayman Chemical
11.7.1 Cayman Chemical Corporation Information
11.7.2 Cayman Chemical Overview
11.7.3 Cayman Chemical SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cayman Chemical SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cayman Chemical Recent Developments
11.8 ChemScence
11.8.1 ChemScence Corporation Information
11.8.2 ChemScence Overview
11.8.3 ChemScence SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 ChemScence SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ChemScence Recent Developments
11.9 Creative Enzymes
11.9.1 Creative Enzymes Corporation Information
11.9.2 Creative Enzymes Overview
11.9.3 Creative Enzymes SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Creative Enzymes SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Creative Enzymes Recent Developments
11.10 Crysdot
11.10.1 Crysdot Corporation Information
11.10.2 Crysdot Overview
11.10.3 Crysdot SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Crysdot SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Crysdot Recent Developments
11.11 Dalton Research Molecules
11.11.1 Dalton Research Molecules Corporation Information
11.11.2 Dalton Research Molecules Overview
11.11.3 Dalton Research Molecules SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dalton Research Molecules SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dalton Research Molecules Recent Developments
11.12 Glentham Life Sciences
11.12.1 Glentham Life Sciences Corporation Information
11.12.2 Glentham Life Sciences Overview
11.12.3 Glentham Life Sciences SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Glentham Life Sciences SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Glentham Life Sciences Recent Developments
11.13 Sigma-Aldrich(Merck KGaA)
11.13.1 Sigma-Aldrich(Merck KGaA) Corporation Information
11.13.2 Sigma-Aldrich(Merck KGaA) Overview
11.13.3 Sigma-Aldrich(Merck KGaA) SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sigma-Aldrich(Merck KGaA) SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sigma-Aldrich(Merck KGaA) Recent Developments
11.14 Tocris Bioscience
11.14.1 Tocris Bioscience Corporation Information
11.14.2 Tocris Bioscience Overview
11.14.3 Tocris Bioscience SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tocris Bioscience SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tocris Bioscience Recent Developments
11.15 Tokyo Chemical Industry(TCI)
11.15.1 Tokyo Chemical Industry(TCI) Corporation Information
11.15.2 Tokyo Chemical Industry(TCI) Overview
11.15.3 Tokyo Chemical Industry(TCI) SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tokyo Chemical Industry(TCI) SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tokyo Chemical Industry(TCI) Recent Developments
11.16 Toronto Research Chemicals
11.16.1 Toronto Research Chemicals Corporation Information
11.16.2 Toronto Research Chemicals Overview
11.16.3 Toronto Research Chemicals SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Toronto Research Chemicals SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Toronto Research Chemicals Recent Developments
11.17 ChemFaces
11.17.1 ChemFaces Corporation Information
11.17.2 ChemFaces Overview
11.17.3 ChemFaces SB-525334 Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 ChemFaces SB-525334 Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 ChemFaces Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SB-525334 Industry Chain Analysis
12.2 SB-525334 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SB-525334 Production Mode & Process
12.4 SB-525334 Sales and Marketing
12.4.1 SB-525334 Sales Channels
12.4.2 SB-525334 Distributors
12.5 SB-525334 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 SB-525334 Industry Trends
13.2 SB-525334 Market Drivers
13.3 SB-525334 Market Challenges
13.4 SB-525334 Market Restraints
14 Key Findings in The Global SB-525334 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer